Rights and permissions
About this article
Cite this article
GSK bets on the genomic route to drug safety. React. Wkly. 841, 3 (2001). https://doi.org/10.2165/00128415-200108410-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200108410-00004